This anti-tumor response elicited by IL-36γ was characterized by increased production of IFN-γ by CD4+ cells, CD8+ cells, NK cells and γδ T cells, which ultimately resulted in the reduction of tumor size and higher survival (67). The gene discussed is CD8A; the disease is neoplasm.